Neuramis

Neuramis is a premier line of monophasic hyaluronic acid fillers developed by Medytox in South Korea. Powered by patented SHAPE™ technology (Stabilized Hyaluronic Acid and Purification Enhancement), Neuramis provides double cross-linked HA formulations with ultra-low residual BDDE and high structural purity. Available with integrated Lidocaine, the Neuramis portfolio delivers smooth extrusion, optimal elasticity, and predictable, natural-looking results ranging from fine-line smoothing to deep facial volumizing.